In our study, we identified a series of potential tumor antigens, including SREBF1, LUC7L3, LAMA5, PCGF3, HNRNPH1, KLC4, and OFD1, by systematically analyzing alternative splicing and mutation of genes in patients with HNSCC. The gene discussed is LUC7L3; the disease is head and neck squamous cell carcinoma.